{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:53:01Z","timestamp":1774547581360,"version":"3.50.1"},"reference-count":33,"publisher":"BMJ","issue":"5","funder":[{"name":"Mats Kleberg Foundation"},{"name":"Karolinska Institutet Foundations and Funds"},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A donation from Mr. Fredrik Lundberg"},{"name":"Governmental grants for clinical research to university healthcare in Lund, Sweden"},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the regional ALF agreement between Stockholm County Council and Karolinska Institutet"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic research program in Epidemiology at Karolinska Institutet"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,3,26]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Blood type A antigen on porcine aortic bioprostheses might initiate an immune reaction leading to an increased frequency of structural valve deterioration in patients with blood type B or O. The aim was to analyse the association between ABO blood type and porcine bioprosthetic aortic valve degeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational nationwide cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Swedish population-based study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adult patients (n=3417) who underwent surgical aortic valve replacement and received porcine bioprosthetic aortic valves between 1995 and 2012 from the Swedish Web system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies register. The study database was enriched with information from other national registers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>The patients were categorised into type A\/AB and type B\/O blood groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Primary outcome measure was aortic valve reoperation, and secondary outcomes were heart failure and all-cause mortality. We report risk estimates that account for the competing risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 3417 patients were identified: 1724 (50.5%) with blood type A\/AB and 1693 (49.5%) with blood type B\/O. Both groups had similar baseline characteristics. The cumulative incidence of aortic valve reoperation was 3.4% (95% CI 2.5% to 4.4%) and 3.6% (95% CI 2.6% to 4.6%) in the type B\/O and the A\/AB group, respectively, at 15 years of follow-up (absolute risk difference: \u22120.2% (95% CI \u22121.5% to 1.2%)). There was no significantly increased risk for aortic valve reoperation in patients with blood type B\/O compared with type A\/AB (HR 0.95, 95%\u2009CI 0.62 to 1.45). There was no significant difference in absolute or relative risk of heart failure or death between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found no significant association between patient blood type and clinical manifestations of structural valve deterioration following porcine aortic valve replacement. Our findings suggest that it is safe to use porcine bioprosthetic valves without consideration of ABO blood type in the recipient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT02276950\" ext-link-type=\"clintrialgov\">NCT02276950<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-029109","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T09:56:36Z","timestamp":1557136596000},"page":"e029109","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["ABO blood type and risk of porcine bioprosthetic aortic valve degeneration: SWEDEHEART observational cohort study"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct02276950","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Michael","family":"Persson","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Universitetssjukhuset, Heart and Vascular Theme, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustaf","family":"Edgren","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Cardiology, Sodersjukhuset AB, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Dal\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Universitetssjukhuset, Heart and Vascular Theme, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Glaser","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Cardiology, Sodersjukhuset AB, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L","family":"Olsson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hematology and Transfusion Medicine, Lunds Universitet, Lund, Sweden"},{"name":"Department of Clinical Immunology and Transfusion Medicine, Laboratory Medicine Office of Medical Service, Region Sk\u00e5ne, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Franco-Cereceda","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Universitetssjukhuset, Heart and Vascular Theme, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J","family":"Holzmann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Functional Area of Emergency Medicine, Huddinge, Karolinska Universitetssjukhuset, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-0263","authenticated-orcid":false,"given":"Ulrik","family":"Sartipy","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Universitetssjukhuset, Heart and Vascular Theme, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,5,5]]},"reference":[{"key":"2025120617570074000_9.5.e029109.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.23.3.221"},{"key":"2025120617570074000_9.5.e029109.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv580"},{"key":"2025120617570074000_9.5.e029109.3","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"2017","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2025120617570074000_9.5.e029109.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.715"},{"key":"2025120617570074000_9.5.e029109.5","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12044"},{"key":"2025120617570074000_9.5.e029109.6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/xen.12260","article-title":"Characterization of immunogenic Neu5Gc in bioprosthetic heart valves","volume":"23","author":"Reuven","year":"2016","journal-title":"Xenotransplantation"},{"key":"2025120617570074000_9.5.e029109.7","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12406","article-title":"Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts","volume":"25","author":"Barone","year":"2018","journal-title":"Xenotransplantation"},{"key":"2025120617570074000_9.5.e029109.8","first-page":"222","article-title":"Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults","volume":"22","author":"Park","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"2025120617570074000_9.5.e029109.9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1185395"},{"key":"2025120617570074000_9.5.e029109.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01441.x"},{"key":"2025120617570074000_9.5.e029109.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3308"},{"key":"2025120617570074000_9.5.e029109.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.09.047","article-title":"Determination of complete sequence information of the human ABO blood group orthologous gene in pigs and breed difference in blood type frequencies","volume":"640","author":"Choi","year":"2018","journal-title":"Gene"},{"key":"2025120617570074000_9.5.e029109.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025120617570074000_9.5.e029109.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2025120617570074000_9.5.e029109.15","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.198804"},{"key":"2025120617570074000_9.5.e029109.16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/icvts\/ivy030","article-title":"Validity of the Swedish Cardiac Surgery Registry","volume":"27","author":"Vikholm","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2025120617570074000_9.5.e029109.17","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/trf.12986","article-title":"The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility","volume":"55","author":"Edgren","year":"2015","journal-title":"Transfusion"},{"key":"2025120617570074000_9.5.e029109.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2025120617570074000_9.5.e029109.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0316-1"},{"key":"2025120617570074000_9.5.e029109.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9350-y"},{"key":"2025120617570074000_9.5.e029109.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025120617570074000_9.5.e029109.22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3618"},{"key":"2025120617570074000_9.5.e029109.23","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"2025120617570074000_9.5.e029109.24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/1536867X1701700212","article-title":"stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function","volume":"17","author":"Mozumder","year":"2017","journal-title":"Stata J"},{"key":"2025120617570074000_9.5.e029109.25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1536867X1501500112","article-title":"Estimating and Modeling Relative Survival","volume":"15","author":"Dickman","year":"2015","journal-title":"Stata J"},{"key":"2025120617570074000_9.5.e029109.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-152"},{"key":"2025120617570074000_9.5.e029109.27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaip.2014.04.016","article-title":"Porcine or bovine valve replacement in 3 patients with IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose","volume":"2","author":"Mozzicato","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025120617570074000_9.5.e029109.28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jocs.12764","article-title":"Premature Bioprosthetic Aortic Valve Degeneration Associated with Allergy to Galactose-Alpha-1,3-Galactose","volume":"31","author":"Hawkins","year":"2016","journal-title":"J Card Surg"},{"key":"2025120617570074000_9.5.e029109.29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jtcvs.2017.05.041","article-title":"When meat allergy meets cardiac surgery: A driver for humanized bioprosthesis","volume":"154","author":"Ankersmit","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025120617570074000_9.5.e029109.30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/all.13238","article-title":"Meat allergy associated with galactosyl-\u03b1-(1,3)-galactose (\u03b1-Gal)-Closing diagnostic gaps by anti-\u03b1-Gal IgE immune profiling","volume":"73","author":"Jappe","year":"2018","journal-title":"Allergy"},{"key":"2025120617570074000_9.5.e029109.31","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2011.0046"},{"key":"2025120617570074000_9.5.e029109.32","doi-asserted-by":"crossref","unstructured":"Yagi K , Holowaychuk MK . Manual of veterinary transfusion medicine and blood banking. Ames, Iowa: Wiley Blackwell, 2016:321\u201333.","DOI":"10.1002\/9781118933053.ch23"},{"key":"2025120617570074000_9.5.e029109.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030729"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-029109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T01:57:09Z","timestamp":1765072629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-029109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,5]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bmjopen-2019-029109"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-029109","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}